Peptides for Sale: Market Trends, Brand Comparisons, and Quality Certifications
Published: 13 7 月, 2026 20:01
Author: Mei Schmidt
Abstract: The global peptides market, projected to reach $68.5 billion by 2030 (CAGR 9.2%), is driven by anti-aging and research applications. Leading brands like Bachem and Genscript dominate via GMP-certified facilities, while smaller vendors offer cost advantages but risk purity inconsistencies (HPLC <98%). Key certifications (ISO 9001, USP) ensure quality. Buyers must prioritize lyophilized storage (-20°C) and third-party COAs to mitigate degradation risks, aligning with EEAT standards for safe procurement.